Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Zhendong Antai Biological Pharmaceutical is a core subsidiary of the Shanxi Zhendong Pharmaceutical Group, specializing in the development and manufacturing of modern Traditional Chinese Medicine (TCM) and chemical pharmaceuticals. Located in Jinzhong, Shanxi, the company operates advanced GMP-certified production lines for various dosage forms, including large and small volume injections, tablets, and capsules. Its product portfolio is heavily focused on oncology, cardiovascular health, and anti-infectives, featuring well-known products like Aidi Injection and Compound Kushen Injection. The company integrates traditional herbal medicine with modern extraction and purification technologies to provide standardized therapeutic solutions. Beyond TCM, it produces a wide range of generic chemical drugs and is actively exploring the biological and peptide drug space. As a key entity within a publicly traded group, it serves as a major manufacturing hub and contributes to the group's extensive domestic distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Zhendong Antai Biological Pharmaceutical.